LBA38 Pembrolizumab versus cetuximab, concomitant with radiotherapy (RT) in locally advanced head and neck squamous cell carcinoma (LA-HNSCC): Results of the GORTEC 2015-01 'PembroRad' randomized trial
| Autor: | F. Drouet, A. Pechery, M. Rives, Alexandre Coutte, M. Wanneveich, Julian Biau, Joël Guigay, J.B. Prevost, X. Liem, Yungan Tao, Jean Bourhis, Marc Alfonsi, Lionnel Geoffrois, Jean-Marc Tourani, Cedrik Lafond, Elodie Vauleon, Anne Auperin, Christian Sire, X. Sun, Laurent Martin |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Oncology
medicine.medical_specialty Cetuximab business.industry medicine.medical_treatment Locally advanced Hematology Pembrolizumab medicine.disease Head and neck squamous-cell carcinoma law.invention Radiation therapy Randomized controlled trial law Concomitant Internal medicine medicine business medicine.drug |
| Zdroj: | Annals of Oncology. 31:S1168 |
| ISSN: | 0923-7534 |
| DOI: | 10.1016/j.annonc.2020.08.2268 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|